ASX AnnouncementsCure Brain Cancer Foundation Research Grant3 Jun 20220Patrys is pleased to share news that the Telethon Kids Institute has been awarded significant funding from the Cure Brain…
MediaMergermarket | Interview with Dr James Campbell30 May 20220Patrys CEO and MD, Dr James Campbell, was recently interviewed by Louise Weihart at Mergermarket, to discuss the deal potential…
MediaABC NEWS | May 20229 May 20220Patrys CEO and Managing Director, Dr James Campbell, is presenting at the 16th Bioshares Biotech Summit to be hosted in…
ASX AnnouncementsQuarterly Activities Report and 4C28 Apr 20220Patrys has published its Quarterly Activities Report and 4C Quarterly Cash Flow Report. Highlights for this Quarter have included: Work…
ASX AnnouncementsPatrys strengthens executive team26 Apr 20220Patrys today announced the appointment of Dr Rebecca Tunstall to the role of Vice President, Corporate Development. As a key…
News UpdateNew research: Scientists determine structure of a DNA damage ‘First Responder’ protein23 Mar 20220Scientists at the Sloan Kettering Institute have debunked a 20-year guiding paradigm for how the 9-1-1 clamp – a protein…
MediaVideoVIDEO | Dr James Campbell on Proactive28 Feb 20220Patrys CEO and MD, Dr James Campbell, was interviewed by Proactive’s Andrew Scott today to discuss the importance of the…
ASX AnnouncementsPAT-DX3 Cell Line Selected28 Feb 20220Patrys today announced that it has now developed and optimised a stable cell line for production of our full-sized IgG…
News UpdateADC Deals Making Headlines8 Feb 20220Late last year, Patrys announced new data from a preclinical study that demonstrated potential for using our deoxymab antibodies as…
ASX AnnouncementsQuarterly Activities Report and 4C31 Jan 20220Patrys has today published its Quarterly Activities Report and 4C Quarterly Cash Flow Report. Standout achievements for this Quarter have…